Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utilization of a Cutaneous Therapy In Situ Microdevice
NCT07352566Phase 4Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Aug 2026
- Primary completion
- Jun 2030
- Countries
- 1
01
Overview
Phase 4, single-arm trial in psoriasis and atopic dermatitis (AD), sponsored by University of California, San Francisco. Primary endpoints: Number of participants with adverse events at 1 year and Proportion of retrieved devices with assessable tissue at 1 year. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
psoriasisatopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07352566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07352566.